Larvol Delta - Blade-Therapeutics-Announces-Successful-Completion-of-Phase-1-Clinical-Study-that-Evaluated-CoAdministration-of-Cudetaxestat-with-Either-of-Two-Approved-Therapies-for-Idiopathic-Pulmonary-Fibrosis

cudetaxestat (BLD 0409) - Blade Therap

https://www.businesswire.com/news/home/20220112005261/en/Blade-Therapeutics-Announces-Successful-Completion-of-Phase-1-Clinical-Study-that-Evaluated-Co-Administration-of-Cudetaxestat-with-Either-of-Two-Approved-Therapies-for-Idiopathic-Pulmonary-Fibrosis

Jan 12, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next